SEARCH RESULTS
News
The Australian Federal Government has announced that Medicare will fund high-tech PSMA PET scans for men with advanced prostate cancer.
Movember funding has supported a world-first trial which has shown Lu-PSMA therapy is safe and effective for men with newly diagnosed localised prostate cancer.
Sexual health and wellbeing is the number one problem for men diagnosed with prostate cancer. Movember wants to change that.
How does stress affect your mental and physical health? Know the signs and symptoms. Learn about coping with stress.
A new prostate cancer treatment has shown similar survival rates to chemotherapy, but with fewer side effects.
Movember supports Lu-PSMA, a revolutionary new prostate cancer treatment.
Guinness world record attempt for the longest singles tennis match, over 3 days playing, to raise funds and awareness for Movember.
Movember celebrates 20 years by announcing 20 celebrity ambassadors leading the charge for men’s health.
The PSMA PET scan helps doctors determine the best prostate cancer treatment plan for men with advanced prostate cancer.
The IRONMAN EMPRO sub-study is a Movember funded prostate cancer research study to improve care and quality of life for men
Movember announces a global investment over three years in six grants across Australia, Canada and the UK to better implement patient-reported measures into clinical care.
We’re proud to launch our first ever Sexual Health Advisory Groups – bringing together the world’s top experts to change how prostate cancer treatment impacts sex and intimacy. See how.
Where you were born. How much money you make. Your ethnicity, race and gender. These, and other factors, shape the cancer care you receive. But today, Movember pushes back. By investing $5.5m (AUD), over three years, in 18 grants to create more equitable prostate cancer care.
What is anxiety? What are the signs and symptoms of anxiety in men? How do you deal with anxiety? Find out how to get help.
A ground-breaking trial supported by Movember has shown that combining two different drugs could delay the progression of advanced prostate cancer by an average of five months.
A Peter MacCallum Cancer Center study, part-funded by Movember, has led to a break-through in the treatment of early-stage prostate cancer.
